Relationship Between Placenta Accreta Index Score and Management in Placenta Accreta Patients in RSUP Dr. M. Djamil Padang

Authors

  • Nabilah Azhari Differences In Serum IL-6 Levels between First-Trimester Normal Pregnancy and Spontaneous Abortion
  • Defrin Defrin Sub Division of Fetomaternal Medicine, Obstetrics and Gynecology Department, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang, West Sumatera, Indonesia
  • Nurhayati Nurhayati Department of Parasitology, Faculty of Medicine, Andalas University, Padang, West Sumatera, Indonesia

DOI:

https://doi.org/10.25077/aoj.9.1.124-133.2025

Keywords:

Hysterectomy, Placenta Accreta, PAI score

Abstract

Introduction : Placenta acreta index is a scoring system using ultrasound parameters used to diagnose placenta accreta. Parameters included are the number of previous caesarean section, location of the placenta, grading of lacunae, presence of bridging blood vessels, thickness of the myometrium. The management of placenta accreta is conservative and definitive management, where the definitive management performed is hysterectomy. The purpose of this study was to determine the relationship between PAI score and placenta accreta management in patients with placenta accreta at Dr. M. Djamil Hospital Padang.

Method : This type of research was observational analytic with cross sectional research design. This study was conducted in the medical record section uses a total sampling technique of 184 patients. Data analysis used univariate analysis, bivariate with Chi square test.

Result : The results of this study showed that 67.9% of patients with PAI≥4 scores, 56.5% of patients who underwent hysterectomy, and after the statistical test obtained a p value <0.001, then H0 was rejected, meaning that there was a relationship between placenta accreta index scores and placenta accreta management.

Conclusion : It is conclude from the results of this study there is a significant relationship between PAI score and placenta accreta management (P<0.05) in placenta accreta patients.

Keywords: Hysterectomy, placenta accreta, PAI score

References

Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018;219(6):B2–16.

Kansouha AM, Eldinb EMS. Maternal outcomes after different surgical techniques in placenta accreta: a prospective study. J Med Sci Res. 2018;1(4):306–11.

Wahyu Wijaya D, Uyun Y, Rahardjo S. Penggunaan skor Indeks Plasenta Akreta (IPA) sebagai prediktor manajemen perioperatif seksio sesarea pasien dengan plasenta previa totalis suspek akreta. J Anestesi Obstet Indones. 2020;3(2):111–8.

Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-Associated costs, 1998-2011. J Matern Neonatal Med. 2015 Apr 2;29(7):1–7.

Happe SK, Yule CS, Spong CY, Wells CE, Dashe JS, Moschos E, et al. Predicting placenta accreta spectrum. J Ultrasound Med. 2020;40(8):1–10.

Rac MWF, Dashe JS, Wells CE, Moschos E, McIntire DD, Twickler DM. Ultrasound predictors of placental invasion: The Placenta Accreta Index. Am J Obstet Gynecol. 2014 Mar 1;212(3):1.e1-1.e7.

Bansal S, Suri J, Bajaj SK, Ahluwalia C, Pandey D, Mittal P. Role of Placenta Accreta Index for Diagnosis of Placenta Accreta Spectrum in High-Risk Patients. J Obstet Gynecol India [Internet]. 2022;72(s1):55–60. Available from: https://doi.org/10.1007/s13224-021-01541-7

Shazly SA, Nassr AA. Placenta accreta spectrum basic science, diagnosis, classification and management. Springer Nature Switzerland AG; 2023. 201 p.

Varlas VN, Bors RG, Birsanu S, Maxim B, Clotea E, Mihailov M. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center. J Med Life. 2021;14(3):367–75.

Kharisma Y, Agustina H, Suryanti S, Dewayani BM, Hernowo BS. Maternal characteristics and histopathological features of placenta accreta spectrum in dr. hasan sadikin general hospital bandung, period 2015–2020. Althea Med J. 2022;9(1):55–60.

Qatrunnada A, Antonius PA, Yusrawati. Faktor risiko dan luaran maternal plasenta akreta in Dr . M . Djamil Padang general hospital. Obgynia. 2018;1(2):1–6.

Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: A large prospective cohort. Am J Perinatol. 2014;31(9):799–804.

Aldhi. Uji diagnostik skor plasenta akreta indeks pada kejadian plasenta akreta di rsup. dr. m. djamil padang. 2022.

El Gelany S, Mosbeh MH, Ibrahim EM, Mohammed M, Khalifa EM, Abdelhakium AK, et al. Placenta Accreta Spectrum (PAS) disorders: Incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: A prospective study. BMC Pregnancy Childbirth. 2019;19(1):1–8.

Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study. PLoS One. 2012;7(12).

Ferry H, Wahyudi T, T AA. Faktor Risiko Kejadian Plasenta Previa Pada Ibu Hamil di RSU dr. Soedarso Pontianak Tahun 2009-2011. 2012;1:1–12.

Yeni CM, Andayani H, Aulia, Indirayani I, Razali R. The Association betweeen Cesarean Section and Placenta Accreta. Indones J Obstet Gynecol. 2022;10(3):127–32.

Jauniaux E, Fox KA, Einerson B, Hussein AM, Hecht JL, Silver RM. Perinatal assessment of complex cesarean delivery: beyond placenta accreta spectrum. Am J Obstet Gynecol [Internet]. 2023;229(2):129–39. Available from: https://doi.org/10.1016/j.ajog.2023.02.021

Farquhar CM, Li Z, Lensen S, McLintock C, Pollock W, Peek MJ, et al. Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: A case-control study. BMJ Open. 2017;7(10):1–9.

Kyozuka H, Yamaguchi A, Suzuki D, Fujimori K, Hosoya M, Yasumura S, et al. Risk factors for placenta accreta spectrum: Findings from the Japan environment and Children’s study. BMC Pregnancy Childbirth. 2019;19(1):1–7.

Zosmer N, Hubinont C, Nicolaides KH, Collins SL. The Impact of Placenta Previa with Placenta Accreta Spectrum Disorder on Fetal Growth. 2020;54(5):86–96.

Morlando M, Sarno L, Napolitano R, Capone A, Tessitore G, Maruotti GM, et al. Placenta accreta: Incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand. 2013;92(4):457–60.

Aziz MA, Wulandari DR. Characteristics of Patients with Morbidly Adherent Placenta at Dr. Hasan Sadikin Hospital Bandung. Indones J Obstet Gynecol Sci. 2023;6(1):28–34.

Carusi DA. The placenta accreta spectrum: Epidemiology and risk factors. Clin Obstet Gynecol. 2018;61(4):1–10.

Belfort A, Mchael A. Placenta accera. Soc Matern Med Am J Obstet Gynecol. 2011;7.

Hull A., Resnik R. Placenta previa, placenta accreta, abruptio placenta, and vasa previa. creasy renik’s Matern -fetal Med Princ Pract. 2009;728–9.

Thang NM, Anh NTH, Thanh PH, Linh PT, Cuong TD. Emergent versus planned delivery in patients with placenta accreta spectrum disorders: A retrospective study. Med (United States). 2021;100(51):E28353.

Nelson T, Chang E, Goodier C, Mateus-Nino J. 209: Validation of the Placenta Accreta Index (PAI): Improving the antenatal diagnosis of the morbidly adherent placenta. Am J Obstet Gynecol [Internet]. 2017;216(1):S133–4. Available from: https://dx.doi.org/10.1016/j.ajog.2016.11.114

Goh WA, Zalud I. Placenta accreta: Diagnosis, management and the molecular biology of the morbidly adherent placenta. J Matern Neonatal Med. 2016;29(11):1795–800.

Zhang D, Yang S, Hou Y, Su Y, Shi H, Gu W. Risk factors, outcome and management survey of placenta accreta in 153 cases: A five-year experience from a hospital of Shanghai, China. Int J Clin Exp Med. 2017;10(8):12509–16.

Sentilhes L, Goffinet F, Kayem G. Management of placenta accreta. Acta Obstet Gynecol Scand. 2013;92(10):1125–34.

Haba RM, Pristavu AI, Cobzeanu ML, Carauleanu A, Sadiye Scripcariu I, Vasilache IA, et al. Predicting Placenta Accreta Spectrum Disorders in a Cohort of Pregnant Patients in the North-East Region of Romania—Diagnostic Accuracy of Ultrasound and Magnetic Resonance Imaging. Diagnostics. 2022;12(9):1–13.

Agarwal S, Agarwal A, Chandak S. Role of placenta accreta index in prediction of morbidly adherent placenta: A reliability study. Ultrasound. 2021;29(2):92–9.

Varlas VN, Bors RG, Birsanu S, Al E. Maternal and Fetal Outcome In Placenta Accreta Spectrum (PAS) Associated with Placenta Previa : A Retrospective Analysis From A Tertiary Center. 201AD;14(3):367–75.

Lakwa H El, Sanad Z, A.Hamza H, Al E. Evaluation of Placenta Accreta Index to Predict Placental Invasion in Patiets with Placenta Previa. Menoufia Med J. 2019;32:1359–64.

Widayat W, Friadi A, Bacthiar H. Diagnostic Test On Modified Score Of Cesarean Section History In Placenta Accreta Index In Predicting Placenta Accreta Diagnosis In Rsup Dr M Djamil. Andalas Obstet Gynecol J. 2021;5(2):215-230. doi:10.25077/aoj.5.2.215-230.2021

Putri IF, Ariadi A. The Relationship Between The Placenta Accreta Index (PAI) Score and The Incidence of Placenta Accreta In Patients Giving Birth in The Obstetrics Department Of RSUP.Dr.M. Djamil Padang. Andalas Obstet Gynecol J. 2019;2(2):78-82. doi:https://doi.org/10.25077/aoj.2.2.78-82.2018

Downloads

Published

2025-01-22

How to Cite

Azhari, N., Defrin, D., & Nurhayati, N. (2025). Relationship Between Placenta Accreta Index Score and Management in Placenta Accreta Patients in RSUP Dr. M. Djamil Padang. Andalas Obstetrics And Gynecology Journal, 9(1), 124–133. https://doi.org/10.25077/aoj.9.1.124-133.2025

Issue

Section

RESEARCH ARTICLE